<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" >

   <HEAD>

	<TITLE>Antimetabolites - Analysis of Nucleotides Level in Cellular Assays</TITLE>

	<!--[if IE 6]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->

    <!--[if IE 7]><meta http-equiv="Refresh" content="0; url=http://www.novocib.com/IE7/index.html"><![endif]-->

    <META http-equiv=Content-Type content="text/html; charset=iso-8859-1">

	<META name=Title content="Mechanism of Action - Nucleotide Analysis">

	<META name=Author content="NovoCIB (contact@novocib.com)">

	<META name=Subject content=">

	<META name=Description content="Analytical service for measuring nucleotide level in cells validated with antimetabolites inhibitors of nucleotide synthesis">

	<META name=Keywords content="Nucleotide extraction, Nucleotide HPLC separation, Nucleotide quantification"> 

	<META content=en name=Language>

	<META content=" name=Expires>

	<META content="NOVOCIB � 2006" name=Distribution>

	<META content=All name=Robots>

	   <!-- css -->

	   <LINK href="css/Stylesmaller.css" type=text/css rel=stylesheet>

	   <!-- favico -->

	   <LINK href="http://www.novocib.com/favicon.ico" rel="shortcut icon">

	   <link rel="stylesheet" media="screen" type="text/css" title="Style" href="css/Stylesmaller.css">

<!-- end favico -->



<!-- script du menu -->

<script type="text/javascript" src="JavMenu.js"></script>

 <!-- d�t�ction du navigateur -->

<script type="text/javascript" src="navdetecteur.js"></script>



<!-- important pour que les vieux navigateurs ne comprennent pas le CSS -->

<style type="text/css">

    @import "Stylesmaller.css";

</style>



</head>

<body>

<div id="page">



<!--[if lt IE 8]><div align=left class="smallRed">This site is designed for IE 8 or IE 9. We are working for compatibility with lower versions. For better convenience, please visit us with IE 8, IE 9, Google Chrome or Firefox, or any other compatible navigator</div><![endif]-->



<!-- HEADER -->

<div id="header">

  <div id="headerLogo"><a href="http://www.novocib.com" title="NovoCIB Home Page"><img src="images/logo NovoCIB1.png" width="247" height="122"/></a></div>

    <p>&nbsp;

     </script>

<script src="//platform.linkedin.com/in.js" type="text/javascript">

 lang: en_US

</script>

<script type="IN/FollowCompany" data-id="5048147" data-counter="none"></script>

    <div id="headerSlogan"><SPAN class=ChapterThirdTitle><em>Reliable solutions for nucleotide assessment</em></SPAN><img src="images/HorizBarMenu.gif" width=380 /></div>

<div><a href="mailto:contact@novocib.com?subject=Contact" class="MenuContact" title="Contact">Contact</a>&nbsp;&nbsp;</div> <br /><br />

</div>

<!-- End HEADER -->



<!-- SQUARE RIGHT -->

<div id="SquareRight" class="small">

  

  <div align="center" class=ChapterThirdTitle style4>Award</div>

  <div align=center>Dr Larissa Balakireva, CEO &amp; Founder of NovoCIB, was awarded with the Trophy of

      <br /><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank>"Femmes en Or 2011, Femme de l'Innovation"</a>

      <br />in September 2011

  </div>.

  <div align=center><a href="http://www.aufeminin.com/evenement/femmes-en-or/" Title="Femmes en Or 2011" class="boldRedAct" target=_blank><img src="images/trophees femmes en or.jpg"/ width=100 ></a>

  </div>

  

    

</div>

<!-- End SQUARE RIGHT -->





<!-- MENU PRINCIPAL, HORIZONTAL -->

<div id="menu">

  <ul id="MenuDeroul">

    <li><a href="Purified_Active_Enzymes.html"><strong>PURIFIED<br />

    ENZYMES</strong></a>

        <ul>

            <li><a href="Recombinant_Purine_Metabolism_Enzymes.html">Purine Metabolism Enzymes</a>

                <ul>

                    <li><a href="IMPDH_Recombinant_Enzyme.html">IMPDH Enzymes<br /><span class="ItemNameHoriz">Inosine Monophosphate Dehydrogenase</span></a>

                        <ul>

                            <li><a href="Human_Recombinant_IMPDH.html">Human IMPDH</a></li>

                            <li><a href="Bacterial_Recombinant_IMPDH.html">Bacterial IMPDH</a></li>

                        </ul>

                    </li>

                    <li><a href="Human_Recombinant_PNP.html">PNP Enzyme<br /><span class=ItemNameHoriz>Purine Nucleoside Phosphorylase</span></a></li>

                     <li><a href="Xanthine_Dehydrogenase_XDH.html">XDH Enzyme<br /><span class=ItemNameHoriz>Xanthine dehydrogenase</span></a></li>

                    <li><a href="Human_Recombinant_HGPRT.html">HGPRT Enzyme<br /><span class=ItemNameHoriz>Hypoxanthine-guanine phosphoribosyltransferase</span></a></li>

                </ul>

            </li>

            <li><a href="Recombinant_Nucleoside_Kinases.html">Nucleoside Kinase  Nucleotidase</a>

                <ul>

                    <li><a href="Recombinant_Adenosine_Kinase.html">ADK Enzyme<br /><span class=ItemNameHoriz>Adenosine Kinase</span></a></li>

                    <li><a href="Recombinant_Deoxycytidine_Kinase.html">dCK Enzyme<br /><span class=ItemNameHoriz>Deoxycytidine Kinase</span></a></li>

                    <li><a href="Recombinant_UMP-CMP_Kinase.html">CMK Enzyme<br /><span class=ItemNameHoriz>UMP-CMP Kinase</span></a></li>

                    <li><a href="Recombinant_5'-nucleotidase.html">cN-II Enzyme<br /><span class=ItemNameHoriz>cytosolic 5'-nucleotidase II</span></a>            </li>

                </ul>

            </li>

            <li><a href="Bacterial_Bioluminescence_Enzymes.html">Bacterial Bioluminescence Enzymes</a>

                <ul>

                    <li><a href="Bacterial_Luciferase.html">Bacterial Luciferase, Highly Pure<br /><span class="ItemNameHoriz">from <em>Photobacterium phosphoreum</em></span></a></li>

                    <li><a href="Bacterial_FMN_Reductase.html">FMN Reductase<br /><span class="ItemNameHoriz">for Bacterial Bioluminescence</span></a>            </li>

                </ul>

            </li>

      </ul>

    </li>

    <li><a href="Nucleotides_Life_Science.html"><strong>NUCLEOTIDES<br /> 

      LIFE SCIENCE<br />

    </strong></a>	

        <ul>

          <li><a href="Convenient_Assay_Kits.html">Assay Kits</a>

          <li><a href="Cellular_Nucleotides_Analysis.html">HPLC Analysis</a>

  </ul>

   <li><a href="Freshness_Assay_Kits.html"><strong>NUCLEOTIDES<br />

      FRESHNESS</strong></a>

       <ul>

              <li><a href="Freshness_Principle.html">Kit Principle</a>

             <li><a href="Freshness_Protocol.html">How It Works</a>

             <li><a href="Case_Studies.html">Case Studies</a>

            <ul><li><a href="Fish_Freshness.html">Fish</a>

             <li><a href="Meat_Freshness.html">Meat</a>    

              </ul></li></ul>

    </li>

    <li><a href="Nucleotide_Analysis_Services.html"><strong>DIETARY<br />

      NUCLEOTIDES</strong></a>

      <ul> 

           

             <li><a href="Yeast_Extract_Nucleotide_Analysis.html">Yeast Extract</a></li>

            <li><a href="Infant_Formula_Nucleotide_Analysis.html">Infant Formula</a></li>

            <li><a href="Aquaculture_Nucleotide_Analysis.html">Aquaculture Feed</a></li>

             <li><a href="Feed_Nucleotide_Analysis.html">Feed &amp; Pet Food</a></li>

            <li><a href="By-Products_Nucleotides.html">By-Products Valorisation</a></li> 

            </ul>

      </li>

   <li><a href="ATP_Breakdown_Assay_Kit.html"><strong>SLAUGHTER<br />

     NUCLEOTIDES<br />

    </strong></a>	

        <ul>

        <li><a href="ATP_breakdown_salmon.html">Fish </a></li>

        <li><a href="ATP_breakdown_meat.html">Meat</a></li>

        </ul>

    </li>

  </ul>



</div>



<!-- End MENU PRINCIPAL, HORIZONTAL -->





<!-- Sub Menu, Vertical -->

<!-- End Sub Menu, Vertical -->

<br />

<!-- Tax Credit announcement -->

<!-- End Tax Credit announcement -->





<!-- page content -->

   

<div id="content" class=default>

  <div align="justify">

    <!-- Mechanism Of Action by Nucleotide Profiling -->

    <h2 class="ChapterThirdTitle">Analytical Service for Validation of Inhibitors of Nucleotide Synthesis</a></h2>

    <div class=default> 

<p><strong>Principle: </strong><br/> 

  <strong>Cellular</strong> <strong>Nucleotide Profiling Service </strong>is an analytical service  for mesuring nucleotide level in antimetabolite-treated cells. More than 31 cellular (deoxy-) ribonucleotides (mono-, di-, and triphosphate) are extracted by SPE procedure, separated by ion-paired HPLC system in one-run and quantified. <br />

  <!-- Table of WCS assays --></p>

<table align=center border=2 cellpadding=2 cellspacing=0 class=mediumbold>

<tr bordercolor=#cc0000 align=center>

                   <td width="162" align=center class="boldRed">Assays                   </td>

                   <td width="266" align=center class="boldRed">Targeted Enzyme(s)

           <br />

                       / Targeted Nucleotide Synthesis Pathway                   </td>

          <td width="178" align=center class="boldRed">Antimetabolite <br/></td>

               </tr>

      		   <tr bordercolor=#cc0000>

                   <td align=center><a href="http://www.novocib.com/IMPDH_Inhibition_Whole_Cell_Screening.html" title="IMPDH inhibition: Whole Cell Assay" class="boldRedAct">Cellular Assay for IMPDH inhibitors</a>                   </td>

                 <td align=center valign=middle><span class="medium">Inosine Monophosphate Dehydrogenase

                     </span><br />

                     <span class="medium">(IMPDH)</span>                 </td>

       	         <td valign=middle><div align="center"><span class="medium">Ribavirin

       	           <br />                   

       	           Mycophenolic Acid</span> <span class="medium">(MPA) </span></div></td>

               </tr>

               <tr bordercolor=#cc0000>

		         <td align=center><a href="http://www.novocib.com/RNR_Inhibition_Whole_Cell_Screening.html" title="RNR inhibition: Whole Cell Assay" class="boldRedAct">Cellular Assay for RNR inhibitors

                       <br />

		         </a>                 </td>

           	       <td align=center valign=middle><span class="medium">Ribonucleotide Reductase</span><span class="medium"><br/>

       	           (RNR)</span>                   </td>

                   <td valign=middle class="medium"><div align="center">Hydroxyurea

                       (HU)<br />

                       Gemcitabine

                 </div></td>

               </tr>

               <tr bordercolor=#cc0000>

			       <td height="67" align=center><a href="http://www.novocib.com/IMPDH_Inhibition_Whole_Cell_Screening" title="Multi-targeted antifolates: Whole Cell Assay" class="boldRedAct">Cellular Assay for Antifolates<br />

         </a></td>

           	       <td align=center valign=top class="medium">&bull; <em>de novo</em> Purine synthesis :

                     <br />

                     GAR transformylase, AICAR transformylase

               <br />&bull; Thymidylate Synthase (TS) </td>

             <td valign=top><div align="center"><br /><br />

               <span class="medium">Methotrexate (MTX) </span></div></td>

          </tr>

   	    </table>

<p><span class="big14boldRed">Validated </span>with antimetabolites (known inhibitors of nucleotide synthesis): MPA, hydroxyurea, methotrexate, ribavirin, mizoribine, leflunomide, gemcitabine. These reference drugs do impact differently on nucleotide metabolism, each showing its own mode of action through a specific nucleotide profile.

           

      Any new compound's mode of action is analyzed by establishing its nucleotide profile which is then compared with those obtained with reference drugs. <br/>

      Download our brochure <a href="images/NovoCIB MOA Studies - Nucleotide Profiling.pdf" target=_blank class="mediumboldRedAct" title="Download our PDF doc">"Mode of Action Studies by Nucleotide Profiling"&nbsp;<img width=20 src="images/pdficon_large.gif" /></a><br />

  </p></div></div>

  

  <div id="PrincipalItem">

  <div align="justify">

    <!-- Intro -->

    <span class="ChapterThirdTitle">Cellular Nucleotides Profiling - Analytical Service</span><br /><br />

    <div>

      To study the effect of nucleoside analogues on the whole spectra of cellular purine and pyrimidine ribo- and deoxyribonucleotides, <strong>NOVO</strong><span class="boldRed">CIB</span> has developed an original cell-based analytical approach in which more than 31 (deoxy)ribonucleotides (mono-, di-, triphosphate) and nucleotide co-factors are extracted from cultured cells, separated by ion-pared chromatography and quantified.

    <br />

    <br />

    </div>

    <div align=center><img src="images/Whole Cell Assay Process.png" width=500 />

    </div>

    <br />These cellular assays were validated with anti-viral and anti-cancer nucleoside analogues (<em>e.g.</em> <strong>ribavirin</strong>, <strong>gemcitabine</strong>) and known anti-metabolites (<strong>mycophenolic acid</strong>, <strong>leflunomide</strong>, <strong>hydroxyurea</strong>, <strong>methotrexate</strong>).

    <br />

  <!-- End Intro -->

  </div>

  

  <br />

  

  <div id="PrincipalItem">

    <!-- IMPDH inhibition: Whole Cell Screening -->

    <p><a name="IMPDH inhibition: Whole Cell Screening"><a href="http://www.novocib.com/IMPDH_Inhibition_Whole_Cell_Screening" class="ChapterThirdTitle">Cellular Assay for IMPDH inhibitors</a></a>

    <div class=default><strong>Aim:</strong> This Research Contract Service has been specially tailored to validate Inosine Monophosphate Dehydrogenase (IMPDH) inhibition by a given compound in cultured cells. The assay consists in extracting, identifying and quantifying by HPLC the intracellular concentration of <strong>guanosine nucleotides (GMP, GDP and GTP) and IMP</strong> in cells treated by a compound.

           This cellular assay was validated with <strong>mycophenolic acid (MPA)</strong>, <strong>ribavirin</strong> and <strong>mizoribin</strong>, recognized inhibitors of IMPDH. <br/>When applied for the study of nucleoside analogues (NA), this assay can also reveal the formation of their mono-, di-, and triphosphate forms, indicating that nucleoside analogues enter the cells and are readily phosphorylated by cellular kinases. 

  <br /><br />

           <div align=right class="mediumbold">Know more about Novo<span class="mediumboldRed">CIB</span>'s <a href="http://www.novocib.com/IMPDH_Inhibition_Whole_Cell_Screening.html" class=mediumboldRedAct>Cell-based IMPDH inhibiton assay</a></a>           </div>

      </div>

    </p>

    <!-- End IMPDH inhibition: Whole Cell Screening -->

  </div>

  

  <br />

  

  <div id="PrincipalItem">

    <!-- RNR inhibition: Whole Cell Screening -->

    <p><a name="RNR inhibition: Whole Cell Screening"><a href="http://www.novocib.com/RNR_Inhibition_Whole_Cell_Screening" class="ChapterThirdTitle">Cellular Assay for RNR inhibitors</a></a>

    

    <div class=default><strong>Aim:</strong> This Research Contract Service has been specially tailored to <strong>validate Ribonucleotide Reductase (RNR) inhibition</strong> by a given compound in cultured cells. The assay consists in extracting, identifying and quantifying by HPLC the intracellular concentration of <strong>deoxynucleotides di- and triphosphate</strong> in cells treated by a compound.

            The assay was validated with <strong>hydroxyurea</strong> and <strong>gemcitabine</strong> in HeLa cultured cells.

      </div>

       <div align=right class="mediumbold">Know more about Novo<span class="mediumboldRed">CIB</span>'s <a href="http://www.novocib.com/RNR_Inhibition_Whole_Cell_Screening.html" class=mediumboldRedAct>Cell-based RNR inhibiton assay</a>

       </div>

       </p>

    <!-- End RNR inhibition: Whole Cell Screening -->

  </div>

  

  <br />

  

  <div id="PrincipalItem">

    <!-- Multi-targeted Antifolates: Whole Cell Screening-->

    <p><a name="Multi-targeted Antifolates: Whole Cell Screening"><a href="http://www.novocib.com/Antifolates_Whole_Cell_Screening" class="ChapterThirdTitle">Cellular Assay for Antifolates</a></a>

    <div class=default><strong>Aim:</strong>	This Research Contract Service has been specially tailored to <strong>validate inhibition of <em>de novo</em> biosynthesis of purine and pyrimidne nucleotides</strong> by a given compound in cultured cells. After incubation of cultured cells with the inhibitor, nucleotides are extracted, separated, identified and quantified by UV-HPLC.

           The assay was validated with <strong>methotrexate</strong> in HeLa cultured cells.

           <br />

       </div>

       <div align=right class="mediumbold">Know more about Novo<span class="mediumboldRed">CIB</span>'s <a href="http://www.novocib.com/Antifolates_Whole_Cell_Screening.html" class=mediumboldRedAct>Cellular assay for Antifolates</a></div>

         <!-- End Multi-targeted Antifolates: Whole Cell Screening -->

  </div>

    

  

  <br />



<div id="PrincipalItem">



    <!-- Intro -->

    <H2 class="ChapterThirdTitle">Customized Nucleotide Analysis </H2>

    <strong>NOVO</strong><span class="boldRed">CIB</span> has initially developed its expertise in Nucleotide Analysis to study the drug impact on the cell metabolism of nucleotides. The methodology we implemented allows us to extend the application field of <strong>NOVO</strong><span class="boldRed">CIB</span>'s expertise in nucleotide analysis and to provide nucleoside analysis services for many other purposes such as, for instance, life science or food quality control.

    <br />

    <br />Extracts from cultured cells, blood cells, body fluids are routinely analyzed in our lab but many other materials can be subjected to a feasibility study for nucleotide analysis. Please feel free to <a href="mailto:contact@novocib.com?subject=Customized%20Nucleotide%20Analysis:%20Information%20request" class="defaultboldAct">contact us</a> for any question.

    <br />

    <!-- End Intro -->

    

  </div>

  

  <br />

  



    <!-- Customized Nucleotide Profiling Analysis -->

    <div class=default><strong>Aims:</strong> Analysis of the Nucleoside and Nucleotide content in biological samples. <br />

           <br />The Nucleotide Analysis procedures implemented by <strong>NOVO</strong><span class="boldRed">CIB</span> have been specially developed to study the impact of drugs on the cell metabolism of nucleosides and nucleotides by comparison of metabolic profiles of treated <em>vs.</em> untreated cells. However, Nucleotide Analysis can be a major concern for many other purposes and <strong>NOVO</strong><span class="boldRed">CIB</span>'s know-how can be adapted for the analysis of other materials. Examples of nucleotide analysis are presented in detail on this website: Baby Milk analysis, Fish / Seafood Freshness control... (see the related links above right for further detail).

           <br />

           <br />The technical presentation of <strong>NOVO</strong><span class="boldRed">CIB</span>'s Customized Nucleotide Analytical services is presented here through the example of application field for which it has been first developed: analysis of drug-treated and untreated cells. In this case, it enables to:

           <br />&bull; reveal the metabolic changes due to the drug action, either on the purine or on the pyrimidine pathway,

           <br />&bull; identify the metabolites whose levels are modified by the drug treatment,

           <br />&bull; trace back to the metabolic step(s) altered by the drug, and to its likely target(s).

           <br />

           <br /><strong>Cell culture and treatment:</strong> The choice of the cell line and culture conditions has been optimized to get highly reproducible results. Assays are usually done with human hepatoma cell line Huh7. Cells are grown in DMEM supplemented with FCS (5%), glutamine (1mM), sodium pyruvate (1mM) and maintained in exponential phase. Cells are seeded on 10cm-dishes and allowed to adhere overnight. The drug is added next day at the agreed concentration and at a cell confluence of about 50%.

           <br />The following metabolites are routinely analyzed*:

           <table class=mediumbold align=center><strong>

               <tr align=left>

                   <td width=90>ATP</td>

                   <td width=90>ADP</td>

                   <td width=90>AMP</td>

                   <td width=90>Uridine</td>

                   <td>Hypoxanthine</td>

               </tr>

               <tr align=left>

                   <td>GTP</td>

                   <td>GDP</td>

                   <td>GMP</td>

                   <td>dGTP</td>

                   <td>Tryptophane*</td>

               </tr>

               <tr align=left>

                   <td>UTP</td>

                   <td>UDP</td>

                   <td>IMP</td>

                   <td>dATP</td>

                   <td>&nbsp;</td>

               </tr>

               <tr align=left>

                   <td>CTP</td>

                   <td>CDP</td>

                   <td>UMP</td>

                   <td>dUTP</td>

                   <td>&nbsp;</td>

               </tr>

               <tr align=left>

                   <td>Guanine</td>

                   <td>Uracyl</td>

                   <td>CMP</td>

                   <td>dTTP</td>

                   <td>&nbsp;</td>

               </tr>

               <tr align=left>

                   <td>Cytidine</td>

                   <td>Guanine</td>

                   <td>Guanosine</td>

                   <td>Adenosine</td>

                   <td></td>

               </tr></strong>

           </table>

     <div class=medium></div>

           <br /><strong>Cultured cell:</strong> Nucleosides and Nucleotides Analysis is usually performed by extraction of &asymp;10<sup>7</sup> treated cells, per compound and per concentration tested. Control untreated cells are cultured under the same conditions to provide a reference metabolic profile.

           <br />Depending on the cell line or the experimental conditions, a 0.5-1.10<sup>5</sup> cell-extract can be sufficient to analyze the major metabolites (<em>e.g.</em> ATP, ADP�).

           <br /><strong>Blood cells:</strong> Typically, a 200&micro;l-sample of blood is sufficient to analyze the major metabolites in Red Blood Cells (RBC), and a 1ml-sample for Peripheral Blood Mononuclear cells(PBMC).

           <br />If needed, for instance to focus on naturally low-level metabolites, larger samples can be prepared, <em>e.g.</em> up to 10<sup>8</sup> of cultured cells.

           <br />

           <br /><strong>Nucleosides & nucleotides separation and analysis:</strong> The extraction and separation procedures have been optimized and specially developed by <strong>NOVO</strong><span class="boldRed">CIB</span>. After a 48h-treatment, nucleosides and nucleotides are extracted; Nucleosides, nucleotides mono-, di-, and triphosphates, deoxynucleotides triphosphates and bases are separated by ion-pairing HPLC (Agilent 1100) with a Zorbax EclipsePlus C18 column and quantified using an Agilent ChemStation software. The resulting values are normalized by cell number. A mixture of 30 authentic standards (Sigma Aldrich, Roth) is run before and after every set of samples analysis.

           <br />

           <!-- Standards Spectrum -->

           <table width="450" align=center cellspacing=10>

               <tr>

                   <td><strong>Figure 1:</strong> Separation by ion-pairing HPLC of a 6.6pmol / 20�l standard mixture of 30 nucleosides, nucleotide mono-, di-, and triphosphates, deoxynucleotide triphosphates and bases

                       <div align=right class="big14boldRed"><sub><strong>V</strong></sub> <span class=medium>mouse over to enlarge</span></div>

                   </td>

               </tr>

           </table>

           <table align=center>

               <tr>

                   <td align=center><div class="zoomWidthW400-600"><img src="images/Standards Spectrum.png" /></div>                   </td>

               </tr>

           </table>

           <!-- End Standards Spectrum -->

           

           <!-- Huh-7 Spectrum -->

           <table width="450" align=center cellspacing=10>

               <tr>

                   <td><strong>Figure 2:</strong> Quantification of intracellular metabolites in Huh-7 non-treated cells

                       <br />

                       <div align=right class="big14boldRed"><sub><strong>V</strong></sub> <span class=medium>mouse over to enlarge</span></div>

                   </td>

               </tr>

           </table>

           <table align=center>

               <tr>

                   <td align=center><div class="zoomWidthW400-600"><img src="images/HuhSpectrum.png" /></div>

                   </td>

               </tr>

           </table>

           <!-- End Huh-7 Spectrum -->

           

           <!-- Huh-7 content: table -->

           <table border="1" align=center class=mediumbold>

               <tr align=center>

                   <td width=100><div align="center">Metabolites                   </div></td>

                   <td colspan="2"><div align="center">pmol / 10<sup>6</sup> cells *</div></td>

                   <td width=100><div align="center">Published data **</div></td>

               </tr>

               <tr align=center>

                   <td>UMP                   </td>

                   <td width=75><div align="right">728.1                   </div></td>

                   <td width=75><div align="left">+/- 56.8</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td>GMP</td>

                   <td><div align="right">34.4                   </div></td>

                   <td><div align="left">+/- 4.8</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td>IMP                   </td>

                   <td><div align="right">72.7                   </div></td>

                   <td><div align="left">+/- 21.4</div></td>

                   <td>130                   </td>

               <tr align=center>

                   <td>NAD                   </td>

                   <td><div align="right">1,825.1</div></td>

                   <td><div align="left">+/- 155.5</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td>UDP-Glu </td>

                   <td><div align="right">1,113.9</div></td>

                   <td><div align="left">+/- 87.1</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td> AMP</td>

                   <td><div align="right">122.7</div></td>

                   <td><div align="left">+/- 12.9</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td> UDP</td>

                   <td><div align="right">1,730.3</div></td>

                   <td><div align="left">+/- 207.1</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td> CTP                   </td>

                   <td><div align="right">2,754.5</div></td>

                   <td><div align="left">+/- 165.4</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td>ADP                                      </td>

                   <td><div align="right">4,652.4                  </div></td>

                   <td><div align="left">+/- 609.8</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td>UTP                   </td>

                   <td> <div align="right">2,494.2</div></td>

                   <td><div align="left">+/- 156.1</div></td>

                   <td>                   </td>

               </tr>

               <tr align=center>

                   <td>GTP</td>

                   <td><div align="right">1,449.7 </div></td>

                   <td><div align="left">+/- 81.4</div></td>

                   <td>1,540                   </td>

               </tr>

               <tr align=center>

                   <td>ATP</td>

                   <td><div align="right">6,561.0 </div></td>

                   <td><div align="left">+/- 346.0</div></td>

                   <td>6,580                   </td>

               </tr>

               <tr>

                   <td colspan=4 width=350>* Mean +/- SD for 5 independent experiments

                       <br />** J. Balzarini <em>et al.</em> (1993)

                   </td>

               </tr>

           </table>

           <!-- End Huh-7 content: table -->

           <br /><strong>Nucleotide profiling:</strong> For every nucleotide and nucleoside metabolite, drug-treated / non-treated cells concentration ratios are calculated and graphically reported. The base line indicates the control level.

           <br />

           <span class="FloatRight"><a href="#top" class="ReturnToTop">(^Top)</a></span>

           <br />

           <!-- Bibliography -->

           <table class=small cellSpacing=0 cellPadding=5 align=center>

		       <tr><td valign=top><img src="images/iconsml.gif" width=100/>

                   </td>

			       <td><p><strong>References (with links to PubMed)</strong><br />

                       <a href="http://www.ncbi.nlm.nih.gov/pubmed/7901217" class=smallAct target=_blank title="Go to PubMed">J. Balzarini <em>et al.</em> (1993): <strong>Eicar (5-ethynyl-1-�-D-ribofuranosylimidazole-4-carboxamide): a novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis</strong> <em>J. Biol. Chem.</em> 268(33), 24591�24598</a>

                       </p>

                   </td>

	           </tr>

           </table>

           <!-- End Bibliography -->

           <div align=right class="mediumbold">Download this document&nbsp;<a href="images/NovoCIB Customized Nucleotide Analysis.pdf" target=_blank class="mediumboldRedAct" title="NovoCIB Customized Nucleotide Analysis">"NovoCIB Customized Nucleotide Analysis"&nbsp;<img width=20 src="images/pdficon_large.gif" /></a>

           </div>

      

       <div><strong>Please feel free to <a href="mailto:contact@novocib.com?subject=Customized%20Nucleotide%20Analysis:%20Information%20request" class=TabServRed title="Customized Nucleotide Analysis: Information request">contact us</a> for any question or matter of feasibility.</strong>       </div>

       </p>

    <!-- End Customized Nucleotide Profiling Analysis -->

  </div>

  

  <br />

  

  <div align="center">

    <table border=1 cellspacing=1 bordercolor=#cc0000>

        <tr align="center" bgcolor="#FFCC00" bordercolor=#ffffff>

            <td><span class="big16boldBlack">Related Links</span>

            </td>

        </tr>

        <tr align="left" valign=top bordercolor=#f5f5f5>

            <td class="RelatedLinksBullet">&bull; <a href="http://www.novocib.com/Infant_Formula_Nucleotide_Analysis" class="defaultAct">Infant Formula Nucleotide Analysis</a>

                <br />

                &bull; <a href="http://www.novocib.com/Freshness_Assay_Kits" class="defaultAct"> Fish &amp; Meat Freshness Analysis</a>            </td>

        </tr>

    </table>

  </div>

</div></div>



<!-- End page content -->



<!-- Go to Top of Page -->

<div id="GoToTopOfPage"></div>

<!-- End Go to Top of Page -->



<!-- footer -->

<div id="footer"><SPAN class="Update">Last Update: 2014/06/16</SPAN><SPAN class="Copyright"> &copy; All Right Reserved | Copyright &reg; NovoCIB | L.Balakireva 2022 | </SPAN><a href="http://www.novocib.com/Legal_Notice" class="Legal" valign=top title="Legal Notice">Legal Notice</a></div>

<!-- End footer -->

</div>



<script type="text/javascript">

    initMenu();

</script>



<script>

  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){

  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),

  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)

  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');



  ga('create', 'UA-47165485-1', 'novocib.com');

  ga('send', 'pageview');



</script>

</body></html>